As of 2024, Spain leads European sold production of vaccines for veterinary medicine, generating 461.87 million euros. France and Germany follow with 306.66 and 139.99 million euros respectively. Hungary, the United Kingdom, and Croatia have comparatively lower outputs of 77.877, 10.081, and 4.9618 million euros. In 2023, Spain showed an 8.76% increase, while France experienced a decline of 10.4%. Germany had a modest growth of 1.0%, with Hungary and the United Kingdom increasing by 1.58% and 7.64% respectively. Croatia slightly decreased by 0.75%. Over the past five years, the compounded annual growth rate shows varying trends among these countries.
Future trends to watch include potential growth accelerations in Spain and the United Kingdom due to increasing investments and innovation in veterinary vaccines. Monitoring regulatory changes, technological advancements, and market demand dynamics will be crucial for understanding shifts in production volumes across these countries.
Top countries in Sold Production of Vaccines for Veterinary Medicine by Country
| # | 6 Countries | Euros | Last Year | YoY | 5-years CAGR | |
|---|---|---|---|---|---|---|
| 1 | 1 Spain | 461,870,000 | 2023 | +7.51% | +8.76% | View data |
| 2 | 2 France | 306,660,000 | 2023 | +0.55% | -10.4% | View data |
| 3 | 3 Germany | 139,990,000 | 2023 | +3.02% | +1% | View data |
| 4 | 4 Hungary | 77,877,000 | 2023 | +2.51% | +1.58% | View data |
| 5 | 5 United Kingdom | 10,081,000 | 2023 | +4.08% | +7.64% | View data |
| 6 | 6 Croatia | 4,961,800 | 2023 | +1.3% | -0.75% | View data |
